Trials / Completed
CompletedNCT02406287
A Controlled Study of the Aqueous Humor Dynamics of AR-13324 Ophthalmic Solution in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Aerie Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the effect of netarsudil (AR-13324) ophthalmic solution on aqueous humor dynamics relative to its placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Netarsudil (AR-13324) Ophthalmic Solution | Topical ophthalmic solution |
| DRUG | Netarsudil (AR-13324) Ophthalmic Solution Placebo | Ophthalmic solution once a day |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2015-04-02
- Last updated
- 2016-09-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02406287. Inclusion in this directory is not an endorsement.